RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 46 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health, U.S.A
Grant: R01CA271523,R01DK127738,R01CA152108,R01CA163489,R35CA253178
NCI NIH HHS
Grant: R01 CA152108
NHLBI NIH HHS
Grant: R01 HL133828
NCI NIH HHS
Grant: R01 CA163489
NIDDK NIH HHS
Grant: R01 DK127738
NCI NIH HHS
Grant: R35 CA253178
NIAID NIH HHS
Grant: R01 AI123106
NCI NIH HHS
Grant: R01 CA282668
NCI NIH HHS
Grant: R01 CA271523
National Institutes of Health
Grant: 5R35CA253178-04
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
National Institutes of Health
Grant: 5R01DK127738-03
Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells
National Institutes of Health
Grant: 5R01CA163489-07
Isoprenylcysteine Carboxyl Methyltransferase (ICMT) as a Target in NRAS Driven Melanoma - Resubmission - 1
National Institutes of Health
Grant: 5R01CA271523-04
Novel Regulation of Oncogenic NRAS Signaling in Myeloid Malignancies
National Institutes of Health
Grant: 5R01CA152108-04
Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)
FWCI
4.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals